Lexaria BioscienceLEXX
13F holders, Q2 2025 (June 30)21holders −1
2new positions
3sold out
$0.87avg. 13F price*
At the end of Q2 2025, 21 institutions reported holding Lexaria Bioscience Corp. (LEXX) in their 13F filings, down 1 from Q1 2025. 2 opened new positions and 3 sold out. The largest holders were Sabby Management, LLC ($1.0M), Invenomic Capital Management LP ($436K) and Geode Capital Management, LLC ($152K).
- Company
- Lexaria Bioscience Corp.
- CUSIP
- 52886N406
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.0M |
| Exits | 3 | $141K |
All 13F filers, Q1 2025 → Q2 2025: 1,188,628 shares bought and 130,934 shares sold, net +1,057,694 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 21 holders
| Sabby Management, LLC | 8.20% | New | 1,165,144 | $1.0M |
| Invenomic Capital Management LP | 0.02% | Reduce -8.8% | 501,468 | $436K |
| Geode Capital Management, LLC | 0.00% | Add +1.4% | 174,779 | $152K |
| Vanguard Group Inc. | 0.00% | Add +4.4% | 133,554 | $116K |
| Toronto Dominion Bank | 0.00% | Add +2.4% | 133,125 | $116K |
| State Street Corp. | 0.00% | No change | 39,301 | $34K |
| Byrne Asset Management LLC | 0.02% | Add +18.4% | 34,209 | $30K |
| Wealth Enhancement Advisory Services, LLC | 0.00% | Reduce -0.6% | 30,776 | $28K |
| BlackRock, Inc. | 0.00% | No change | 27,445 | $24K |
| Northern Trust Corp. | 0.00% | No change | 18,389 | $16K |
| Bank of Montreal | 0.00% | No change | 14,033 | $12K |
| Royal Bank of Canada | 0.00% | No change | 7,283 | $6K |
| UBS Group AG | 0.00% | New | 6,074 | $5K |
| Oakworth Capital, Inc. | 0.00% | No change | 5,000 | $4K |
| Osaic Holdings, Inc. | 0.00% | Add +15.9% | 2,190 | $2K |
| Wells Fargo & Company | 0.00% | No change | 2,000 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +51.3% | 1,964 | $2K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 382 | $325 |
| Bank of America Corp. | 0.00% | Add +26.3% | 168 | $146 |
| Farther Finance Advisors, LLC | 0.00% | No change | 166 | $144 |
| Gables Capital Management Inc. | 0.00% | No change | 13 | $11 |
"% of holder's portfolio" is LEXX's weight in each manager's 13F, not the share of Lexaria Bioscience Corp. the manager owns.